Amgen Inc. company and executive profile by Barron's. View the latest AMGN company infomation and executive bios.

Shares of Amgen Inc. AMGN rallied 1.13% to $290.33 Friday, on what proved to be an all-around great trading session for the ...

Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN ...

We often feature the Ember Mug 2 in our deals, but there is one major downside to that model. It isn’t really made to be ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Vantage Wealth bulked up its portfolio by increasing its stake in Amgen by 4.2%, now holding over $21.6 million in shares.

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

A look at the shareholders of Amgen Inc. (NASDAQ:AMGN) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 81% ownership. That is ...

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader macroeconomic uncertainty. Stocks have been on a roller-coaster ride since ...

Shares of Amgen Inc. AMGN shed 1.33% to $271.34 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.61% to 5,844.61 and ...